The Interagency Emergency Health Kit 2006 - Medicines and Medical Devices for 10,000 People for Approximately 3 Months - An Interagency Document: Annex: Annex 8. Guidelines for Drug Donations 56 : Information and management

The Interagency Emergency Health Kit 2006 - Medicines and Medical Devices for 10,000 People for Approximately 3 Months - An Interagency Document
(2006; 88 pages) [French] [Spanish]

Índice de contenido

Acknowledgments
Introduction
Chapter 1. Essential medicines and medical devices in emergency situations
	What is an emergency?
	Principles behind the IEHK 2006
	Referral system
	Immunization and nutrition in emergency situations
	Reproductive health
	Malaria
	HIV, AIDS, tuberculosis and leprosy
	Procurement of IEHK 2006
	Post emergency needs
Chapter 2. Selection of medicines and medical devices included in IEHK 2006
	Selection of medicines for IEHK 2006
	Medicines not included in IEHK 2006
	Selection of medical devices for IEHK 2006
	Selection of equipment
	Medical devices not included in IEHK 2006
	Major medicine and medical device changes since the 1998 edition of the emergency health kit
Chapter 3. Content of IEHK 2006
	10 basic units - for health care workers with limited training
	One supplementary unit - for physicians and senior health care workers
	Basic unit (for 1,000 persons for 3 months)
	Supplementary unit (for 10,000 people for 3 months)
Annex
	Annex 1: Basic unit: treatment guidelines
		Anaemia
		Pain
		Diarrhoea
		Fever
		Respiratory tract infections
		Measles
		"Red eye" condition
		Skin conditions
		Sexually transmitted and urinary tract infections
		Preventive care in pregnancy
		Worms
	Annex 2. Assessment and treatment of diarrhoea⁵³
		A-2.1 Assessment of diarrhoeal patients for dehydration
		A-2.2 Treatment of acute diarrhoea (without blood)
	Annex 3. Management of the child with cough or difficult breathing
		A-3.1 Assess the child
		A-3.2 Decide how to treat the child
		A-3.3 Child less than two months old
		A-3.4 Child two months to five years old
		A-3.5 Treatment instructions
			A-3.5.1 Give an antibiotic
			A-3.5.2 Advise mother to give home care (for child age 2 months up to 5 years)
			A-3.5.3 Treat Fever (see also page 27)
	Annex 4: Sample data collection forms
	Annex 5. Sample health card
	Annex 6. Guidelines for suppliers
		Specifications for medicines and medical devices
		Packaging
		Packing list
		Information slips
	Annex 7. Other kits for emergency situations
		Immunization
		Nutrition
		Reproductive health
	Annex 8. Guidelines for Drug Donations⁵⁶
		Selection of drugs
		Quality assurance and shelf-life
		Presentation, packing and labelling
		Information and management
	Annex 9. Model Regulatory Aspects of Exportation and Importation of Controlled Substances
		Introduction
		Standard procedure for international transfer of narcotic and psychotropic substances
		Procedure to be followed in disaster relief
		Outline of standard agreement between supplier and control authorities of exporting countries⁶¹
		Shipment request/notification form for emergency supplies of controlled substances
	Annex 10. References
		Medicines
		Medicine management
		Communicable diseases
		General public health
		Child health
		HIV and STIs
		International travel and health
		Malaria
		Mental health
		Nutrition
		Reproductive health
		Tuberculosis
	Annex 11. Useful addresses
		Partners
		Suppliers
Feedback form

Information and management

10. Recipients should be informed of all drug donations that are being considered, prepared or actually under way.

Justification and explanation

Many drug donations arrive unannounced. Detailed advance information on all drug donations is essential to enable the recipient to plan for the receipt of the donation and to coordinate the donation with other sources of supply. The information should at least include: the type and quantities of donated drugs including their International Nonproprietary Name (INN) or generic name, strength, dosage form, manufacturer and expiry date; reference to earlier correspondence (for example, the letter of consent by the recipient); the expected date of arrival and port of entry; and the identity and contact address of the donor.

11. In the recipient country the declared value of a drug donation should be based upon the wholesale price of its generic equivalent in the recipient country, or, if such information is not available, on the wholesale world-market price for its generic equivalent.

Justification and explanation

This provision is needed solely to prevent drug donations being valued in the recipient country according to the retail price of the product in the donor country. This may lead to elevated overhead costs for import tax, port clearance and handling in the recipient country. It may also result in a corresponding decrease in the public sector drug budget in the recipient country.

Possible exception

In the case of patented drugs (for which there is no generic equivalent) the wholesale price of the nearest therapeutic equivalent could be taken as a reference.

12. Costs of international and local transport, warehousing, port clearance and appropriate storage and handling should be paid by the donor agency, unless specifically agreed otherwise with the recipient in advance.

Justification and explanation

This provision prevents the recipient from being forced to spend effort and money on the clearance and transport of unannounced consignments of unwanted items, and also enables the recipient to review the list of donated items at an early stage.